Terms: = Bone cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Treatment
101 results:
1. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
[TBL] [Abstract] [Full Text] [Related]
2. Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo.
Chen X; Luo Z; Hu Z; Sun D; He Y; Lu J; Chen L; Liu S
Eur J Med Chem; 2024 Feb; 266():116082. PubMed ID: 38232462
[TBL] [Abstract] [Full Text] [Related]
3. Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study.
Zhang W; Chen Z; Sa B
Eur J Gastroenterol Hepatol; 2024 Jan; 36(1):129-134. PubMed ID: 37994618
[TBL] [Abstract] [Full Text] [Related]
4. The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.
Pedersen MA; Gormsen LC; Jakobsen LH; Eyre TA; Severinsen MT; Baech J; Dann EJ; Knapp A; Sahin D; Vestergaard P; El-Galaly TC; Jensen P
Br J Haematol; 2024 Apr; 204(4):1271-1278. PubMed ID: 37957542
[TBL] [Abstract] [Full Text] [Related]
5. Effects of the major formaldehyde catalyzer ADH5 on phenotypes of fanconi anemia zebrafish model.
Mu A; Cao Z; Huang D; Hosokawa H; Maegawa S; Takata M
Mol Biol Rep; 2023 Oct; 50(10):8385-8395. PubMed ID: 37615925
[TBL] [Abstract] [Full Text] [Related]
6. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S; Schuler M; Iyer G; Witt O; Doi T; Qin S; Tabernero J; Reardon DA; Massard C; Minchom A; Lugowska I; Carranza O; Arnold D; Gutierrez M; Winter H; Stuyckens K; Crow L; Najmi S; Hammond C; Thomas S; Santiago-Walker A; Triantos S; Sweiti H; Loriot Y;
Lancet Oncol; 2023 Aug; 24(8):925-935. PubMed ID: 37541273
[TBL] [Abstract] [Full Text] [Related]
7. Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting.
Skafida E; Andrikopoulou A; Terpos E; Markellos C; Moustafa S; Pectasides D; Dimopoulos MA; Zagouri F; Vassilopoulos D
Breast J; 2023; 2023():3614296. PubMed ID: 37293258
[TBL] [Abstract] [Full Text] [Related]
8. Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy.
Köksal M; Kersting L; Schoroth F; Garbe S; Koch D; Scafa D; Sarria GR; Leitzen C; Heine A; Holderried T; Brossart P; Zoga E; Attenberger U; Schmeel LC
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5965-5973. PubMed ID: 36607428
[TBL] [Abstract] [Full Text] [Related]
9. Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature.
Loeffen YGT; Scharloo F; Goemans BF; Heitink-Polle KMJ; Lindemans CA; van der Bruggen T; Hagen F; Wolfs TFW
Pediatr Infect Dis J; 2022 Sep; 41(9):e369-e376. PubMed ID: 35703287
[TBL] [Abstract] [Full Text] [Related]
10. Local Control Outcomes Using Stereotactic Body Radiation Therapy or Surgical Resection for Metastatic Sarcoma.
Gutkin PM; von Eyben R; Chin A; Donaldson SS; Oh J; Jiang A; Ganjoo KN; Avedian RS; Bruzoni M; Steffner RJ; Moding EJ; Hiniker SM
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):771-779. PubMed ID: 35643255
[TBL] [Abstract] [Full Text] [Related]
11. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Fizazi K; Foulon S; Carles J; Roubaud G; McDermott R; Fléchon A; Tombal B; Supiot S; Berthold D; Ronchin P; Kacso G; Gravis G; Calabro F; Berdah JF; Hasbini A; Silva M; Thiery-Vuillemin A; Latorzeff I; Mourey L; Laguerre B; Abadie-Lacourtoisie S; Martin E; El Kouri C; Escande A; Rosello A; Magne N; Schlurmann F; Priou F; Chand-Fouche ME; Freixa SV; Jamaluddin M; Rieger I; Bossi A;
Lancet; 2022 Apr; 399(10336):1695-1707. PubMed ID: 35405085
[TBL] [Abstract] [Full Text] [Related]
12. Vulvar cancer during pregnancy and/or breastfeeding: a report of five cases from a single center study at the University Hospital of Düsseldorf.
Winarno AS; Fehm TN; Hampl M
BMC Pregnancy Childbirth; 2022 Mar; 22(1):207. PubMed ID: 35291960
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Pelvic Lymph Node Recurrence Detected by PSMA PET/CT after Primary Proton Beam Radiotherapy for Prostate cancer].
Ito T; Yamaguchi Y; Fujimoto N; Watabe T; Ishizuya Y; Uemura M; Nonomura N
Hinyokika Kiyo; 2021 Dec; 67(12):543-546. PubMed ID: 34991296
[TBL] [Abstract] [Full Text] [Related]
14. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
Logan IT; Vroobel KM; le Grange F; Perrett CM
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
[TBL] [Abstract] [Full Text] [Related]
15. Stereotactic body radiotherapy for head and neck skin cancer.
Voruganti IS; Poon I; Husain ZA; Bayley A; Barnes EA; Zhang L; Chin L; Erler D; Higgins K; Enepekides D; Eskander A; Karam I
Radiother Oncol; 2021 Dec; 165():1-7. PubMed ID: 34648871
[TBL] [Abstract] [Full Text] [Related]
16. Characteristics and outcomes of patients with multiple myeloma at the Uganda cancer Institute.
Okello CD; Mulumba Y; Omoding A; Ddungu H; Welch K; Thompson CL; Cowan AJ; Cooney MM; Orem J
Afr Health Sci; 2021 Mar; 21(1):67-74. PubMed ID: 34394283
[TBL] [Abstract] [Full Text] [Related]
17. Proton Beam Therapy for cancer in Children and Adults: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(1):1-142. PubMed ID: 34055109
[TBL] [Abstract] [Full Text] [Related]
18.
de Melo-Martin I; Crystal RG
Hum Gene Ther; 2021 Jun; 32(11-12):529-534. PubMed ID: 33752441
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/aldh2 deficiency.
Mu A; Hira A; Niwa A; Osawa M; Yoshida K; Mori M; Okamoto Y; Inoue K; Kondo K; Kanemaki MT; Matsuda T; Ito E; Kojima S; Nakahata T; Ogawa S; Tanaka K; Matsuo K; Saito MK; Takata M
Blood; 2021 Apr; 137(15):2021-2032. PubMed ID: 33512438
[TBL] [Abstract] [Full Text] [Related]
20. Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Rocconi RP; Grosen EA; Ghamande SA; Chan JK; Barve MA; Oh J; Tewari D; Morris PC; Stevens EE; Bottsford-Miller JN; Tang M; Aaron P; Stanbery L; Horvath S; Wallraven G; Bognar E; Manning L; Nemunaitis J; Shanahan D; Slomovitz BM; Herzog TJ; Monk BJ; Coleman RL
Lancet Oncol; 2020 Dec; 21(12):1661-1672. PubMed ID: 33271095
[TBL] [Abstract] [Full Text] [Related]
[Next]
